E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas

Laboratory Investigation

Volumn 79, Issue 4, 1999, Pages 459-465

  Machado, José C ^c   Soares, Paula ^d   Carneiro, Fátima ^d   Rocha, Ana ^d   Beck, Stefanie ^a   Blin, Nikolaus ^a   Berx, Geert ^b   Sobrinho Simões, Manuel ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY OF PORTO   (Portugal)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER CLASSIFICATION; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA;

CADHERINS; CARCINOMA; CODON; CODON, TERMINATOR; EXONS; FRAMESHIFT MUTATION; HUMANS; INTRONS; LOSS OF HETEROZYGOSITY; MUTATION; MUTATION, MISSENSE; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE DELETION; STOMACH NEOPLASMS;

EID: 0032900798     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Antonarakis SE (1998). Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11:1-3.
2. Becker KF and Hofler H (1995). Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 87:1082-1084.
3. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, and Hofler H (1994). E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845-3852.
4. Berx G, Cleton-Jansen AM, Mollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, and van Roy F (1995). E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115.
5. Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, and Cornelisse C (1996). E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925.
6. Berx G, Becker KF, Hofler H, and van Roy F (1998). Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12:226-237.
7. Bukholm IK, Nesland JM, Karesen R, Jacobsen U, and Borresen-Dale A-L (1998). E-cadherin and α-, β-, and γ-catenin protein expression in relation to metastasis in human breast carcinoma. J Pathol 185:262-266.
8. Carneiro F, Seixas M, and Sobrinho-Simões M (1995). New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191:571-584.
9. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, and Hommel G (1996). Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69:184-189.
10. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Hailing K, MacLeod P, Powell SM, Jackson CE, Ponder BAJ, and Caldas C (1998). Identification of germline E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58:4086-4089.
11. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, and Baylin SB (1995). E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199.
12. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, and Reeve AE (1998). E-cadherin germline mutations in familial gastric cancer. Nature 392:402-405.
13. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, and Birchmeier W (1995). Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11: 475-484.
14. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, and Farthing MJ (1997). Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival. Gastroenterology 112:46-54.
15. Kemler R (1993). From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9:317-321.
16. Laurén P (1965). The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64:31-49.
17. Machado JC, Carneiro F, Beck S, Rossi S, Lopes J, Taveira-Gomes A, and Cardoso-Oliveira M (1998). E-cadherin expression is associated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma. Int J Surg Pathol 6:135-144.
18. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, and Funke I (1993). E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53:1690-1695.
19. Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, and Hirohashi S (1996). E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 87:843-848.
20. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, and Hirohashi S (1994). E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91:1858-1862.
21. Overduin M, Harvey TS, Bagby S, Tong KI, Yau P, Takeichi M, and Ikura M (1995). Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267:386-389.
22. 2+ binding site of uvomorulin abolish the adhesive function. Cell 63:1033-1038.
23. Risinger JI, Berchuck A, Kohler MF, and Boyd J (1994). Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7:98-102.
24. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G, Legrand JF, Als-Nielsen J, Colman DR, and Hendrickson WA (1995). Structural basis of cell-cell adhesion by cadherins. Nature 374:327-337.
25. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S, and Hirohashi S (1992). Cadherin dysfunction in a human cancer cell line: Possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res 52:5770-5774.
26. Shino Y, Watanabe A, Yamada Y, Tanase M, Yamada T, Matsuda M, Yamashita J, Tatsumi M, Miwa T, and Nakano H (1995). Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas. Cancer 76:2193-2201.
27. Smith ME and Pignatelli M (1997). The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology 31:107-111.
28. Takeichi M (1991). Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455.
29. Vermeulen S, Van Marck V, Van Hoorde L, van Roy F, Bracke M, and Mareel M (1996). Regulation of the invasion suppressor function of the cadherin/catenin complex. Pathol Res Pract 192:694-707.
30. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, and Hirohashi S (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92:7416-7419.